Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (631-640 of 818) with videos related to

Pageof 82
Sort By:
Oncogene|February 19, 2021
Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesisRochelle Fletcher, Jingshan Tong, Denise Risnik, et al.
Journal for Immunotherapy of Cancer|October 25, 2018
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoireAhmad Tarhini, Yan Lin, Huang Lin, et al.
Ophthalmology|March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical TrialJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Head & Neck|January 12, 2022
Poor treatment tolerance in head and neck cancer patients with low muscle massMarco A Mascarella, Terral Patel, Varun Vendra, et al.
Journal for Immunotherapy of Cancer|March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapyNaiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancerR L Ferris, J L Geiger, S Trivedi, et al.
Retina (Philadelphia, Pa.)|October 7, 2010
Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research networkChristina J Flaxel, Allison R Edwards, Lloyd Paul Aiello, et al.
Retina (Philadelphia, Pa.)|December 30, 2009
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edemaEmily Y Chew, Jonghyeon Kim, Hanna R Coleman, et al.
Viruses|August 28, 2021
APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell CarcinomaDaniel L Faden, Krystle A Lang Kuhs, Maoxuan Lin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 24, 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck SocietyKevin J Contrera, Sagar Kansara, Neerav Goyal, et al.
Pageof 82

Showing results (631-640 of 818) with videos related to

Sort By:
Pageof 82
Oncogene|February 19, 2021
Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesisRochelle Fletcher, Jingshan Tong, Denise Risnik, et al.
Journal for Immunotherapy of Cancer|October 25, 2018
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoireAhmad Tarhini, Yan Lin, Huang Lin, et al.
Ophthalmology|March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical TrialJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Head & Neck|January 12, 2022
Poor treatment tolerance in head and neck cancer patients with low muscle massMarco A Mascarella, Terral Patel, Varun Vendra, et al.
Journal for Immunotherapy of Cancer|March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapyNaiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancerR L Ferris, J L Geiger, S Trivedi, et al.
Retina (Philadelphia, Pa.)|October 7, 2010
Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research networkChristina J Flaxel, Allison R Edwards, Lloyd Paul Aiello, et al.
Retina (Philadelphia, Pa.)|December 30, 2009
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edemaEmily Y Chew, Jonghyeon Kim, Hanna R Coleman, et al.
Viruses|August 28, 2021
APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell CarcinomaDaniel L Faden, Krystle A Lang Kuhs, Maoxuan Lin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 24, 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck SocietyKevin J Contrera, Sagar Kansara, Neerav Goyal, et al.
Pageof 82